Equity Mates Investing PodcastKoala, SpaceX, Eli Lilly, Nike, Anthropic & Pimp my Portfolio with Owen Rask

Pills widen GLP-1 market

5:38–5:58 · 20s

Alec explains how Eli Lilly’s once-a-day GLP-1 pill could boost adoption by avoiding injections, with usage already meaningful across the U.S. population.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.